Oh et al., observed a synergistic effect of targeting both BCL-XL and antioxidant defence systems in Kras mutant colorectal cancer [66], demonstrating the potential for targeting the multifaceted cell-protective roles for Kras in cancer. The gene discussed is KRAS; the disease is cancer.